DMMR COLORECTAL CANCER
Clinical trials for DMMR COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new DMMR COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for DMMR COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Matched conditions: DMMR COLORECTAL CANCER
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could immunotherapy spare some colon cancer patients from surgery?
Disease control Not yet recruitingThis study tests giving an immunotherapy drug (pembrolizumab) before surgery to people with a specific type of colon cancer (dMMR). The goal is to see if the drug can shrink or eliminate the tumor so some patients may avoid surgery and instead be closely monitored. About 152 adul…
Matched conditions: DMMR COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC